FOUND: 2 - What They Never Told You

New ‘synthetic alcohol’ that promises to end hangovers could be available in Ireland in the next five years

he new molecular compound, which has been named Alcarelle, was created by in the UK

Nearly half of Brits say they have had an alcoholic beverage before a social event to boost their confidence - with family gatherings among such occasions

Nearly third of patients on largest trial using psychedelic compound went into rapid remission

Registered charity Mind Medicine Australia (MMA) seeks to help alleviate the suffering and suicide caused by mental illness through expanding novel treatment options to medical practitioners and patients. To that end, it has received new funding support for the development of observational trials of psychedelic-assisted therapies. 

TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.

Neuroscientist, persuasive science communicator and advocate for rationality and openness

The research renaissance into the neuroscience and therapeutic applications of psychedelics represents one of the most promising initiatives in brain science and neuropsychopharmacology, given the huge unmet needs in the therapeutic areas they aim to treat.

Dr Miriam Stoppard looks at promising new research that shows how a psychedelic substance found in magic mushrooms could help people who are trapped in negative thought patterns